Ricardo Encinas-Blazquez

Cordoba, AN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Journal: Molecular cancer
Published: February 27, 2026

An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups.

An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups.

Journal: Endocrine pathology
Published: February 12, 2026

Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomas.

Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomas.

Journal: Molecular biomedicine
Published: June 17, 2025

Exploring RNA biology in pseudomyxoma peritonei uncovers splicing dysregulation as a novel, targetable molecular vulnerability.

Exploring RNA biology in pseudomyxoma peritonei uncovers splicing dysregulation as a novel, targetable molecular vulnerability.

Journal: Cancer gene therapy
Published: December 05, 2024

From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction.

From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction.

Journal: Seminars in cancer biology
Published: November 28, 2024

SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.

SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.

Journal: Science advances
Published: October 02, 2024

The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma.

The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma.

Journal: Cancer gene therapy
Published: April 01, 2024

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential.

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential.

Journal: Journal of experimental & clinical cancer research : CR
Published: June 23, 2023

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.

Journal: Journal of translational medicine
Published: May 05, 2023

Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.

Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.

Journal: Molecular oncology
Published: April 14, 2023

Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response.

Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response.

Journal: Molecular therapy. Nucleic acids
Published: February 09, 2023

The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities.

The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities.

Journal: Reviews in endocrine & metabolic disorders
Published: November 15, 2022
Showing 1-12 of 17

Last Updated: 09/26/2026